Literature DB >> 18374824

Pharmacotherapy of first-episode schizophrenia.

Robert A Rosenheck1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18374824     DOI： 10.1016/S0140-6736(08)60463-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

Review 1.  Drug treatments for schizophrenia: pragmatism in trial design shows lack of progress in drug design.

Authors:  F Cheng; P B Jones
Journal:  Epidemiol Psychiatr Sci       Date:  2013-02-06       Impact factor: 6.892

2.  Oxidative stress in schizophrenia.

Authors:  Marija Bošković; Tomaž Vovk; Blanka Kores Plesničar; Iztok Grabnar
Journal:  Curr Neuropharmacol       Date:  2011-06       Impact factor: 7.363

Review 3.  Relapse prevention in schizophrenia: a systematic review and meta-analysis of second-generation antipsychotics versus first-generation antipsychotics.

Authors:  T Kishimoto; V Agarwal; T Kishi; S Leucht; J M Kane; C U Correll
Journal:  Mol Psychiatry       Date:  2011-11-29       Impact factor: 15.992
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.